Literature DB >> 15107587

Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver.

Minoru Watanabe1, Toshio Kumai, Naoki Matsumoto, Masami Tanaka, Satoshi Suzuki, Tetsuo Satoh, Shinichi Kobayashi.   

Abstract

A relatively large amount of human liver tissue was required to determine the exact activity of human hepatic CYP3A. Although, the quantity of available human liver tissue samples is limited. We measured levels of CYP3A4 mRNA by RT-PCR with a radiolabeled primer specific for CYP3A4 and compared mRNA expression with CYP3A4 protein level and metabolic activity in liver. The level of CYP3A4 mRNA was correlated with the levels of CYP3A4 protein and activity. Our results suggest that CYP3A4 protein and activity levels can be predicted from CYP3A4 mRNA levels determined by RT-PCR and using a very small amount of liver tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107587     DOI: 10.1254/jphs.94.459

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  5 in total

1.  Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells.

Authors:  Madhav Sachar; Edward J Kelly; Jashvant D Unadkat
Journal:  AAPS J       Date:  2019-03-27       Impact factor: 4.009

2.  Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa.

Authors:  Varsha Dhamankar; Mahfoud Assem; Maureen D Donovan
Journal:  Inhal Toxicol       Date:  2015-11-16       Impact factor: 2.724

3.  Genetic predictors of interindividual variability in hepatic CYP3A4 expression.

Authors:  Vishal Lamba; John C Panetta; Stephen Strom; Erin G Schuetz
Journal:  J Pharmacol Exp Ther       Date:  2009-11-24       Impact factor: 4.030

4.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

5.  Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment.

Authors:  Andrew HyoungJin Kim; Sumin Yoon; Yujin Lee; Jieon Lee; Eunjin Bae; Hajeong Lee; Dong Ki Kim; SeungHwan Lee; Kyung-Sang Yu; In-Jin Jang; Joo-Youn Cho
Journal:  J Korean Med Sci       Date:  2018-10-31       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.